Twitter can help predict asthma-related ED visits
Researchers have created a model to predict approximately how many asthma sufferers would visit the ED at a large hospital in Dallas on a…
Technology
Issues up close
For many nurses today, the workplace may feel like uncharted territory. New technologies, bold advances in health care, and a growing urgency to collaborate…
ECRI announces top technology hazards for 2015
The ECRI Institute has announced its Top 10 Health Technology Hazards for 2015, which include alarm hazards, mix-up of IV lines, lack of data…
Do you hear what I hear? Combating alarm fatigue
As you enter your unit to begin your shift, a cacophony of alarms from multiple devices greets you. The cacophony continues throughout your entire…
Nursing practice and work environment
A patient was admitted to the hospital for uncontrolled diabetes. A nurse taking care of her checked her blood glucose level. The glucometer showed…
What you need to know about electronic documentation
Electronic health records (EHRs) are here to stay. Beginning January 1, 2014, all public and private healthcare providers were required to adopt and demonstrate…
CDC develops new faster test for enterovirus D68
On Oct. 14, the Centers for Disease Control and Prevention (CDC) announced that it has started using a new, faster lab test for detecting…
Multitasking with media devices may change brain structure
According to a study in PLOS One, people who frequently use several media devices at the same time have lower grey-matter density in one…
CDC recognizes National Immunization Awareness Month
Click to visit www.cdc.gov/vaccines/events/niam, where you can find information from the CDC concerning this year’s National Immunization Awareness Month.
ANA Immunize resource
Click to visit www.anaimmunize.org, the American Nurses Association’s online immunization resource.
FDA approves Afrezza
On June 27, the U.S. Food and Drug Administration (FDA) approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin to improve glycemic control…
FDA approves drug for treating rare type of non-Hodgkin lymphoma
On July 3, the U.S. Food and Drug Administration (FDA) approved Beleodaq (belinostat) for the treatment of patients with peripheral T-cell lymphoma, a rare…
Twitter can help predict asthma-related ED visits
Researchers have created a model to predict approximately how many asthma sufferers would visit the ED at a large hospital in Dallas…
Issues up close
For many nurses today, the workplace may feel like uncharted territory. New technologies, bold advances in health care, and a growing urgency…
ECRI announces top technology hazards for 2015
The ECRI Institute has announced its Top 10 Health Technology Hazards for 2015, which include alarm hazards, mix-up of IV lines, lack…
Do you hear what I hear? Combating alarm fatigue
As you enter your unit to begin your shift, a cacophony of alarms from multiple devices greets you. The cacophony continues throughout…
Nursing practice and work environment
A patient was admitted to the hospital for uncontrolled diabetes. A nurse taking care of her checked her blood glucose level. The…
What you need to know about electronic documentation
Electronic health records (EHRs) are here to stay. Beginning January 1, 2014, all public and private healthcare providers were required to adopt…
CDC develops new faster test for enterovirus D68
On Oct. 14, the Centers for Disease Control and Prevention (CDC) announced that it has started using a new, faster lab test…
Multitasking with media devices may change brain structure
According to a study in PLOS One, people who frequently use several media devices at the same time have lower grey-matter density…
CDC recognizes National Immunization Awareness Month
Click to visit www.cdc.gov/vaccines/events/niam, where you can find information from the CDC concerning this year’s National Immunization Awareness Month.
ANA Immunize resource
Click to visit www.anaimmunize.org, the American Nurses Association’s online immunization resource.
FDA approves Afrezza
On June 27, the U.S. Food and Drug Administration (FDA) approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin to improve…
FDA approves drug for treating rare type of non-Hodgkin lymphoma
On July 3, the U.S. Food and Drug Administration (FDA) approved Beleodaq (belinostat) for the treatment of patients with peripheral T-cell lymphoma,…
Test Your Knowledge
food insecurity
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.